+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genetic Toxicology Testing Market by Test Type, Technology, End User, Application - Global Forecast to 2030- Product Image
Genetic Toxicology Testing Market by Test Type, Technology, End User, Application - Global Forecast to 2030- Product Image
Sale

Genetic Toxicology Testing Market by Test Type, Technology, End User, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674228
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Genetic Toxicology Testing Market grew from USD 1.65 billion in 2024 to USD 1.83 billion in 2025. It is expected to continue growing at a CAGR of 10.68%, reaching USD 3.03 billion by 2030.

Setting the Stage for Advances in Genetic Toxicology Testing

Genetic toxicology testing stands at the crossroads of innovation and regulatory oversight, serving as a critical pillar in assessing the safety of chemicals, pharmaceuticals, cosmetics, and environmental agents. This report offers a thorough perspective on the current state of testing methodologies, highlighting key drivers that influence strategic decisions within research institutions, biotechnology firms, contract laboratories, and regulatory bodies.

By exploring the interplay between evolving scientific techniques and global regulatory frameworks, this summary provides decision-makers with a concise yet comprehensive understanding of the forces shaping the industry. It underscores the significance of integrating advanced in silico predictions, refined in vitro assays, and ethically responsible in vivo studies to meet both safety objectives and emerging policy expectations.

Through a blend of historical context, market dynamics, and forward-looking analysis, the introduction sets the foundation for a deeper exploration of transformative shifts, segmentation insights, regional nuances, and strategic imperatives. Readers will be equipped to anticipate challenges, capitalize on opportunities, and align their investments with the trajectory of genetic toxicology testing.

Evolving Paradigms Transforming the Testing Landscape

The genetic toxicology arena is undergoing a profound transformation driven by breakthroughs in computational modeling, high-throughput assays, and regulatory initiatives aimed at reducing animal use. Advances in bioinformatics and in silico tools are empowering researchers to predict genotoxic risks with greater precision, while new cell-based platforms and organoid systems are redefining the scope of in vitro experimentation.

Regulatory agencies worldwide are increasingly harmonizing guidelines to emphasize mechanistic understanding and validated non-animal methods. This shift is accelerating the adoption of alternative testing strategies that align with ethical commitments and sustainability goals. Laboratories are investing in automation and digital workflows to improve data quality, reproducibility, and turnaround time.

At the same time, in vivo testing continues to evolve with refined protocols and enhanced welfare standards for rodent and non-rodent models. Combined, these transformative trends are reshaping the competitive landscape, fostering partnerships, and encouraging multidisciplinary collaboration. As the field advances, stakeholders must remain agile to integrate emerging technologies and comply with dynamic regulatory expectations.

Examining the United States Tariff Impact on Testing Dynamics

The introduction of new tariffs on chemical reagents, laboratory instruments, and consumables in 2025 has created notable cost pressures across the genetic toxicology workflow. Research institutions and contract organizations are reevaluating supply chains to mitigate duty increases, often shifting toward regional suppliers or negotiating long-term agreements to stabilize pricing. Equipment manufacturers and service providers are reassessing their operational footprints to maintain competitiveness.

These tariff-induced adjustments are influencing project timelines and budget allocations, prompting stakeholders to explore leaner experimental designs and collaborative purchasing models. In some cases, the cumulative tariff burden has accelerated investments in domestic manufacturing capacity for critical reagents, reducing reliance on high-tariff imports.

Despite these challenges, the industry is demonstrating resilience through strategic sourcing, process optimization, and increased emphasis on cost-efficiency. Organizations that proactively address tariff implications are better positioned to sustain research continuity, meet regulatory deadlines, and deliver high-quality toxicology assessments.

Unveiling Segmentation Trends Across Testing Modalities and Applications

This analysis dissects testing modalities beginning with computational approaches that leverage in silico prediction software and QSAR modeling to anticipate genotoxic potential without physical assays. In vitro techniques encompass the classic Ames test, chromosomal aberration assays, comet assays, and micronucleus assays, each providing distinct mechanistic insights. In vivo studies balance scientific rigor with ethical considerations through non-rodent models such as dogs and rabbits, alongside rodent systems including mice and rats.

Technological capabilities span a spectrum from traditional chromatography-covering gas chromatography and liquid chromatography platforms like HPLC and UPLC-to mass spectrometry, flow cytometry, and advanced imaging cytometry. Next generation sequencing enhances molecular resolution, distinguishing targeted amplicon and exome sequencing approaches from comprehensive whole genome analysis.

End users range from government research labs and university laboratories to emerging and established biotechnology companies. Bulk and specialty chemical producers collaborate with full service and niche contract research organizations, while food and beverage manufacturers maintain safety testing in crop protection, dairy, and meat facilities. Pharmaceutical development relies on generic, global, and specialty drug firms, and regulatory oversight is conducted by agencies such as the EMA, FDA, and PMDA.

Applications span chemical safety assessment for agrochemicals and industrial compounds, cosmetic safety evaluation through dermal irritation and phototoxicity testing, drug discovery phases from lead optimization to preclinical safety, environmental monitoring of air, soil heavy metal and pesticide residues as well as water quality, and food safety testing focused on pathogen detection and residue analysis.

Mapping Regional Dynamics Shaping Growth Trajectories

In the Americas, a mature research infrastructure underpins extensive genetic toxicology programs. The United States leads through robust regulatory frameworks and established contract research capacity, while Canada and select Latin American markets are enhancing local capabilities to support regional demand and reduce import dependencies.

Europe, the Middle East and Africa exhibit diverse dynamics shaped by stringent European Union regulations and growing investment in non-animal testing protocols. Key markets in Western Europe drive technological adoption, while Middle Eastern and African nations are fostering partnerships to develop domestic testing laboratories and regulatory expertise.

Asia-Pacific is marked by rapid expansion in both public and private sectors. China and India are scaling up national research initiatives and building capacity in genomics and toxicology testing. Japan and South Korea continue to refine their regulatory alignment with global standards. Across the region, harmonization efforts and infrastructure development are creating new opportunities for integrated service providers.

Spotlight on Leading Innovators Driving Market Progress

Industry leaders are advancing genetic toxicology through comprehensive service portfolios and strategic collaborations. Major contract research organizations are integrating digital platforms and automation to enhance throughput and data integrity, while specialized testing laboratories are differentiating through advanced molecular assays and niche expertise.

Equipment and reagent suppliers are forging partnerships with software developers to offer end-to-end solutions that streamline workflows and support regulatory compliance. Biotechnology firms are leveraging novel biomarkers and genome editing tools to refine assay sensitivity and predict adverse outcomes with greater confidence.

Collaborative networks among academic institutions, regulatory agencies, and private companies are accelerating method validation and standardization. This cooperative approach is critical for addressing emerging regulatory expectations and industry demands, ultimately driving improved safety assessments and more efficient product development.

Strategic Imperatives for Industry Leadership and Resilience

Leaders in this space should prioritize investment in digital transformation, including artificial intelligence, machine learning and cloud-based data management. Integrating these technologies enables predictive modeling, automated data analysis and seamless collaboration across global teams. Simultaneously, adopting refined in vitro methods and embracing the 3Rs principle reduces reliance on animal models and aligns with evolving ethical and regulatory standards.

Supply chain diversification and regional sourcing strategies will mitigate cost volatility from tariffs and geopolitical factors. Forming strategic alliances with reagent manufacturers and equipment vendors can secure preferential access to critical materials. Additionally, offering bundled service packages with comprehensive data analytics enhances customer value and fosters long-term partnerships.

To maintain competitive differentiation, organizations must develop customer-centric platforms that integrate testing services, regulatory guidance and scientific consulting. Continuous upskilling of laboratory personnel and cross-disciplinary collaboration will ensure agility in adopting emerging assays and responding to shifting regulatory landscapes.

Robust Research Methodology Underpinning Insights

This report is underpinned by a rigorous research methodology combining primary and secondary intelligence. Expert interviews were conducted with senior leaders across testing laboratories, academic institutions, biotechnology firms and regulatory agencies to capture firsthand perspectives on challenges and opportunities.

Secondary research involved a comprehensive review of scientific literature, patent filings, regulatory documents and industry publications. Data triangulation ensured the reliability of insights by cross-validating information from multiple sources. Quality control measures included iterative internal reviews and alignment with recognized best practices in market research.

Analytical frameworks were applied to identify key themes, map technology trajectories and evaluate strategic positioning. The synthesis of qualitative and quantitative inputs provides a robust foundation for the in-depth analysis presented throughout the report.

Synthesis of Key Takeaways and the Way Forward

The genetic toxicology landscape is characterized by a balance of tradition and innovation, where time-tested assays coexist with emerging computational and molecular tools. This executive summary has highlighted transformative shifts, tariff implications, detailed segmentation, regional dynamics and leading industry players.

Key takeaways emphasize the critical importance of integrating advanced in silico and in vitro approaches, diversifying supply chains in response to trade policies, and leveraging strategic alliances to accelerate method development. Regional analysis underscores the unique drivers and opportunities across the Americas, EMEA and Asia-Pacific markets.

Moving forward, stakeholders who embrace digital transformation, ethical testing paradigms and customer-focused service models will be best positioned to thrive. The insights presented serve as a roadmap for navigating complexity, optimizing research processes and delivering reliable safety assessments.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Test Type
    • Computational
      • In Silico Prediction Software
      • QSAR Modeling
    • In Vitro
      • Ames Test
      • Chromosomal Aberration Test
      • Comet Assay
      • Micronucleus Assay
    • In Vivo
      • Non Rodent Model
        • Dog Model
        • Rabbit Model
      • Rodent Model
        • Mouse Model
        • Rat Model
  • Technology
    • Chromatography
      • Gas Chromatography
      • Liquid Chromatography
        • HPLC
        • UPLC
      • Supercritical Fluid Chromatography
    • Flow Cytometry
    • Imaging Cytometry
    • Mass Spectrometry
    • Next Generation Sequencing
      • Targeted Sequencing
        • Amplicon Sequencing
        • Exome Sequencing
      • Whole Genome Sequencing
  • End User
    • Academia And Research Institutes
      • Government Research Labs
      • University Laboratories
    • Biotechnology Companies
      • Emerging Biotechnology Companies
      • Established Biotechnology Companies
    • Chemical Companies
      • Bulk Chemical Companies
      • Specialty Chemical Companies
    • Contract Research Organizations
      • Full Service Organizations
      • Specialized Service Organizations
    • Food And Beverage Manufacturers
      • Crop Protection Testing Facilities
      • Dairy Testing Facilities
      • Meat Safety Testing Facilities
    • Pharmaceuticals
      • Generic Pharmaceutical Companies
      • Global Pharmaceutical Companies
      • Specialty Pharmaceutical Companies
    • Regulatory Authorities
      • European Medicines Agency
      • Food And Drug Administration
      • Pharmaceuticals And Medical Devices Agency
  • Application
    • Chemical Safety Assessment
      • Agrochemicals
      • Industrial Chemicals
    • Cosmetic Safety Assessment
      • Dermal Irritation Testing
      • Phototoxicity Testing
    • Drug Discovery
      • Lead Optimization
      • Preclinical Safety
    • Environmental Monitoring
      • Air Quality Testing
      • Soil Testing
        • Heavy Metal Analysis
        • Pesticide Residue Analysis
      • Water Testing
        • Drinking Water Testing
        • Wastewater Testing
    • Food Safety Testing
      • Pathogen Detection
      • Residue Analysis
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific SE
  • Laboratory Corporation of America Holdings
  • WuXi AppTec Co., Ltd.
  • SGS SA
  • Intertek Group plc
  • Merck KGaA
  • Inotiv, Inc.
  • Altasciences
  • Toxikon, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Genetic Toxicology Testing Market, by Test Type
8.1. Introduction
8.2. Computational
8.2.1. in Silico Prediction Software
8.2.2. QSAR Modeling
8.3. in Vitro
8.3.1. Ames Test
8.3.2. Chromosomal Aberration Test
8.3.3. Comet Assay
8.3.4. Micronucleus Assay
8.4. in Vivo
8.4.1. Non Rodent Model
8.4.1.1. Dog Model
8.4.1.2. Rabbit Model
8.4.2. Rodent Model
8.4.2.1. Mouse Model
8.4.2.2. Rat Model
9. Genetic Toxicology Testing Market, by Technology
9.1. Introduction
9.2. Chromatography
9.2.1. Gas Chromatography
9.2.2. Liquid Chromatography
9.2.2.1. HPLC
9.2.2.2. UPLC
9.2.3. Supercritical Fluid Chromatography
9.3. Flow Cytometry
9.4. Imaging Cytometry
9.5. Mass Spectrometry
9.6. Next Generation Sequencing
9.6.1. Targeted Sequencing
9.6.1.1. Amplicon Sequencing
9.6.1.2. Exome Sequencing
9.6.2. Whole Genome Sequencing
10. Genetic Toxicology Testing Market, by End User
10.1. Introduction
10.2. Academia and Research Institutes
10.2.1. Government Research Labs
10.2.2. University Laboratories
10.3. Biotechnology Companies
10.3.1. Emerging Biotechnology Companies
10.3.2. Established Biotechnology Companies
10.4. Chemical Companies
10.4.1. Bulk Chemical Companies
10.4.2. Specialty Chemical Companies
10.5. Contract Research Organizations
10.5.1. Full Service Organizations
10.5.2. Specialized Service Organizations
10.6. Food and Beverage Manufacturers
10.6.1. Crop Protection Testing Facilities
10.6.2. Dairy Testing Facilities
10.6.3. Meat Safety Testing Facilities
10.7. Pharmaceuticals
10.7.1. Generic Pharmaceutical Companies
10.7.2. Global Pharmaceutical Companies
10.7.3. Specialty Pharmaceutical Companies
10.8. Regulatory Authorities
10.8.1. European Medicines Agency
10.8.2. Food and Drug Administration
10.8.3. Pharmaceuticals and Medical Devices Agency
11. Genetic Toxicology Testing Market, by Application
11.1. Introduction
11.2. Chemical Safety Assessment
11.2.1. Agrochemicals
11.2.2. Industrial Chemicals
11.3. Cosmetic Safety Assessment
11.3.1. Dermal Irritation Testing
11.3.2. Phototoxicity Testing
11.4. Drug Discovery
11.4.1. Lead Optimization
11.4.2. Preclinical Safety
11.5. Environmental Monitoring
11.5.1. Air Quality Testing
11.5.2. Soil Testing
11.5.2.1. Heavy Metal Analysis
11.5.2.2. Pesticide Residue Analysis
11.5.3. Water Testing
11.5.3.1. Drinking Water Testing
11.5.3.2. Wastewater Testing
11.6. Food Safety Testing
11.6.1. Pathogen Detection
11.6.2. Residue Analysis
12. Americas Genetic Toxicology Testing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Genetic Toxicology Testing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Genetic Toxicology Testing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Charles River Laboratories International, Inc.
15.3.2. Eurofins Scientific SE
15.3.3. Laboratory Corporation of America Holdings
15.3.4. WuXi AppTec Co., Ltd.
15.3.5. SGS SA
15.3.6. Intertek Group plc
15.3.7. Merck KGaA
15.3.8. Inotiv, Inc.
15.3.9. Altasciences
15.3.10. Toxikon, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. GENETIC TOXICOLOGY TESTING MARKET MULTI-CURRENCY
FIGURE 2. GENETIC TOXICOLOGY TESTING MARKET MULTI-LANGUAGE
FIGURE 3. GENETIC TOXICOLOGY TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GENETIC TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. GENETIC TOXICOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. GENETIC TOXICOLOGY TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COMPUTATIONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY IN SILICO PREDICTION SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY QSAR MODELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COMPUTATIONAL, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY IN VITRO, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY AMES TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHROMOSOMAL ABERRATION TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COMET ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY MICRONUCLEUS ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY IN VITRO, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY IN VIVO, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY NON RODENT MODEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY DOG MODEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY RABBIT MODEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY NON RODENT MODEL, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY RODENT MODEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY MOUSE MODEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY RAT MODEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY RODENT MODEL, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY HPLC, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY UPLC, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY SUPERCRITICAL FLUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY IMAGING CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY AMPLICON SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY ACADEMIA AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY GOVERNMENT RESEARCH LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY UNIVERSITY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY ACADEMIA AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY EMERGING BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY ESTABLISHED BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHEMICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY BULK CHEMICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY SPECIALTY CHEMICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHEMICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY FULL SERVICE ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY SPECIALIZED SERVICE ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CROP PROTECTION TESTING FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY DAIRY TESTING FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY MEAT SAFETY TESTING FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY GLOBAL PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY SPECIALTY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY REGULATORY AUTHORITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY EUROPEAN MEDICINES AGENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY FOOD AND DRUG ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PHARMACEUTICALS AND MEDICAL DEVICES AGENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY REGULATORY AUTHORITIES, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHEMICAL SAFETY ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY AGROCHEMICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY INDUSTRIAL CHEMICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHEMICAL SAFETY ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COSMETIC SAFETY ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY DERMAL IRRITATION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PHOTOTOXICITY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COSMETIC SAFETY ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRECLINICAL SAFETY, BY REGION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY AIR QUALITY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY SOIL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY HEAVY METAL ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PESTICIDE RESIDUE ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY SOIL TESTING, 2018-2030 (USD MILLION)
TABLE 97. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY WATER TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 98. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY DRINKING WATER TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 99. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY WASTEWATER TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 100. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 101. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 102. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY FOOD SAFETY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 103. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PATHOGEN DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 104. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY RESIDUE ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 105. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY FOOD SAFETY TESTING, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COMPUTATIONAL, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY IN VITRO, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY NON RODENT MODEL, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY RODENT MODEL, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY ACADEMIA AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHEMICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 123. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 124. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY REGULATORY AUTHORITIES, 2018-2030 (USD MILLION)
TABLE 125. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHEMICAL SAFETY ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 127. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COSMETIC SAFETY ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 128. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 129. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 130. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY SOIL TESTING, 2018-2030 (USD MILLION)
TABLE 131. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 132. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY FOOD SAFETY TESTING, 2018-2030 (USD MILLION)
TABLE 133. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COMPUTATIONAL, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY IN VITRO, 2018-2030 (USD MILLION)
TABLE 137. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 138. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY NON RODENT MODEL, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY RODENT MODEL, 2018-2030 (USD MILLION)
TABLE 140. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY ACADEMIA AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHEMICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY REGULATORY AUTHORITIES, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHEMICAL SAFETY ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COSMETIC SAFETY ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 157. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 158. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY SOIL TESTING, 2018-2030 (USD MILLION)
TABLE 159. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 160. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY FOOD SAFETY TESTING, 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 162. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 163. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COMPUTATIONAL, 2018-2030 (USD MILLION)
TABLE 164. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY IN VITRO, 2018-2030 (USD MILLION)
TABLE 165. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 166. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY NON RODENT MODEL, 2018-2030 (USD MILLION)
TABLE 167. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY RODENT MODEL, 2018-2030 (USD MILLION)
TABLE 168. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 170. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 171. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 172. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 173. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY ACADEMIA AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 175. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 176. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHEMICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 177. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 178. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 179. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 180. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY REGULATORY AUTHORITIES, 2018-2030 (USD MILLION)
TABLE 181. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHEMICAL SAFETY ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 183. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COSMETIC SAFETY ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 184. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 185. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 186. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY SOIL TESTING, 2018-2030 (USD MILLION)
TABLE 187. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 188. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY FOOD SAFETY TESTING, 2018-2030 (USD MILLION)
TABLE 189. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 190. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COMPUTATIONAL, 2018-2030 (USD MILLION)
TABLE 191. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY IN VITRO, 2018-2030 (USD MILLION)
TABLE 192. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 193. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY NON RODENT MODEL, 2018-2030 (USD MILLION)
TABLE 194. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY RODENT MODEL, 2018-2030 (USD MILLION)
TABLE 195. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 197. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 198. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 199. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 200. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY ACADEMIA AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 202. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 203. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHEMICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 204. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 205. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 206. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 207. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY REGULATORY AUTHORITIES, 2018-2030 (USD MILLION)
TABLE 208. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHEMICAL SAFETY ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 210. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COSMETIC SAFETY ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 211. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 212. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 213. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY SOIL TESTING, 2018-2030 (USD MILLION)
TABLE 214. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 215. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY FOOD SAFETY TESTING, 2018-2030 (USD MILLION)
TABLE 216. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 217. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COMPUTATIONAL, 2018-2030 (USD MILLION)
TABLE 218. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY IN VITRO, 2018-2030 (USD MILLION)
TABLE 219. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 220. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY NON RODENT MODEL, 2018-2030 (USD MILLION)
TABLE 221. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY RODENT MODEL, 2018-2030 (USD MILLION)
TABLE 222. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 223. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 224. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 225. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 226. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 227. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY ACADEMIA AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 229. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 230. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHEMICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 231. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 232. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 233. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 234. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY REGULATORY AUTHORITIES, 2018-2030 (USD MILLION)
TABLE 235. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHEMICAL SAFETY ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 237. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COSMETIC SAFETY ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 238. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 239. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 240. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY SOIL TESTING, 2018-2030 (USD MILLION)
TABLE 241. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 242. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY FOOD SAFETY TESTING, 2018-2030 (USD MILLION)
TABLE 243. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 244. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COMPUTATIONAL, 2018-2030 (USD MILLION)
TABLE 245. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY IN VITRO, 2018-2030 (USD MILLION)
TABLE 246. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 247. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY NON RODENT MODEL, 2018-2030 (USD MILLION)
TABLE 248. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY RODENT MODEL, 2018-2030 (USD MILLION)
TABLE 249. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 250. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 251. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 252. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 253. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 254. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY ACADEMIA AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 256. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 257. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHEMICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 258. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 259. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 260. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 261. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY REGULATORY AUTHORITIES, 2018-2030 (USD MILLION)
TABLE 262. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHEMICAL SAFETY ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 264. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COSMETIC SAFETY ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 265. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 266. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 267. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY SOIL TESTING, 2018-2030 (USD MILLION)
TABLE 268. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 269. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY FOOD SAFETY TESTING, 2018-2030 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COMPUTATIONAL, 2018-2030 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY IN VITRO, 2018-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY NON RODENT MODEL, 2018-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY RODENT MODEL, 2018-2030 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY ACADEMIA AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHEMICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, 2018-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY REGULATORY AUTHORITIES, 2018-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY CHEMICAL SAFETY ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COSMETIC SAFETY ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY SOIL TESTING, 2018-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY WATER TESTING, 2018-2030 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY FOOD SAFETY TESTING, 2018-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING

Companies Mentioned

The companies profiled in this Genetic Toxicology Testing market report include:
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific SE
  • Laboratory Corporation of America Holdings
  • WuXi AppTec Co., Ltd.
  • SGS SA
  • Intertek Group plc
  • Merck KGaA
  • Inotiv, Inc.
  • Altasciences
  • Toxikon, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages195
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.83 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.03 Billion
Compound Annual Growth Rate10.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Genetic Toxicology Testing Market Size, Share and Trends Analysis Report by Type (in Vitro, in Vivo), Product (Reagents & Consumables, Assays Kit, Services), Assay, Application, and Region 2024-2030 - Product Image

Genetic Toxicology Testing Market Size, Share and Trends Analysis Report by Type (in Vitro, in Vivo), Product (Reagents & Consumables, Assays Kit, Services), Assay, Application, and Region 2024-2030

  • Report
  • 100 Pages
  • Global
From
Genetic Toxicology Testing Market by Product, by Type, by Assay, by End-User, and By Region - Product Image

Genetic Toxicology Testing Market by Product, by Type, by Assay, by End-User, and By Region

  • Report
  • 200 Pages
  • Global
From
Genetic Toxicology Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Genetic Toxicology Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 289 Pages
  • Global
From
Genetic Toxicology Testing Market Report 2025 - Product Image

Genetic Toxicology Testing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Genomics in Drug Discovery and Development. Edition No. 1 - Product Image

Genomics in Drug Discovery and Development. Edition No. 1

  • Book
  • 496 Pages

About the Genetic Toxicology Market

Genetic Toxicology is a field of genomics that focuses on the study of the effects of environmental agents on the genetic material of living organisms. It is used to assess the potential health risks of exposure to environmental agents such as chemicals, radiation, and other environmental stressors. Genetic Toxicology studies the effects of these agents on the genetic material of living organisms, including DNA, RNA, and proteins. It also studies the effects of these agents on the expression of genes and the development of diseases. Genetic Toxicology is used to assess the potential health risks of exposure to environmental agents, and to develop strategies to reduce or eliminate these risks. It is also used to develop new treatments for diseases caused by environmental agents. The Genetic Toxicology market is composed of companies that provide services related to the study of the effects of environmental agents on the genetic material of living organisms. These companies include Genomic Health, Inc., Eurofins Scientific, and Charles River Laboratories. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.